182 related articles for article (PubMed ID: 23268016)
41. [A Case of Perianal Squamous Cell Carcinoma with Left Inguinal Lymph Node Metastasis That Showed a Complete Response More Than Five Years after Chemotherapy and Concomitant Proton Beam Therapy].
Suzuki N; Azami A; Todate Y; Tada T; Waragai M; Honda M; Sato A; Takano Y; Abe T; Nakamura T; Teranishi Y
Gan To Kagaku Ryoho; 2017 Jun; 44(6):525-528. PubMed ID: 28698447
[TBL] [Abstract][Full Text] [Related]
42. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
[TBL] [Abstract][Full Text] [Related]
43. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.
Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801
[TBL] [Abstract][Full Text] [Related]
44. [A Case of Squamous Cell Carcinoma of the Anal Canal with a Perianal Abscess].
Adikrisna R; Udagawa M; Sugita Y; Ishii T; Okamoto H; Yabata E
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2322-4. PubMed ID: 26805351
[TBL] [Abstract][Full Text] [Related]
45. Anus-preservation treatment for anal cancer: retrospective analysis at a single institution.
Chen YW; Yen SH; Chen SY; Huang PI; Shiau CY; Liu YM; Lin JK; Wang LW
J Surg Oncol; 2007 Oct; 96(5):374-80. PubMed ID: 17492635
[TBL] [Abstract][Full Text] [Related]
46. [The therapeutic results and early and late toxicities of the treatment of anal canal carcinoma by radiotherapy or chemoradiotherapy].
Sommer K; Brockmann WP; Wiegel T; Krüll A; Hübener KH; Birk S
Strahlenther Onkol; 1991 Aug; 167(8):445-51. PubMed ID: 1909466
[TBL] [Abstract][Full Text] [Related]
47. Chemoradiotherapy for anal squamous cell carcinoma.
Houlihan OA; O'Neill BD
Surgeon; 2016 Aug; 14(4):202-12. PubMed ID: 27118047
[TBL] [Abstract][Full Text] [Related]
48. Patterns of recurrence in squamous cell carcinoma of the anal canal.
Luna-Pérez P; Fernández A; Labastida S; Lira-Puerto V; Vázquez-Curiel JA; Herrera L
Arch Med Res; 1995; 26(3):213-9. PubMed ID: 8580670
[TBL] [Abstract][Full Text] [Related]
49. [A case report of chemoradiotherapy combined with S-1 responding to squamous cell carcinoma of the anal canal].
Baba H; Kuwabara H; Wakabayashi M; Nakamura H; Sanada T; Baba H; Nakajima K; Goseki N
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2280-2. PubMed ID: 22202355
[TBL] [Abstract][Full Text] [Related]
50. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
[TBL] [Abstract][Full Text] [Related]
51. [Squamous cell carcinoma of the canal anal].
Guimarães AP; Matos D; Segreto R; Forones NM
Arq Gastroenterol; 2001; 38(1):9-13. PubMed ID: 11582966
[TBL] [Abstract][Full Text] [Related]
52. [Multidisciplinary Treatment for Squamous Cell Carcinoma of the Anal Canal].
Karasawa H; Ohnuma S; Watanabe K; Tsuchiya T; Imoto H; Aoki T; Kudoh K; Tanaka N; Nagao M; Abe T; Musha H; Motoi F; Kamei T; Naitoh T; Unno M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):2009-2010. PubMed ID: 29394850
[TBL] [Abstract][Full Text] [Related]
53. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
Kato K; Muro K; Minashi K; Ohtsu A; Ishikura S; Boku N; Takiuchi H; Komatsu Y; Miyata Y; Fukuda H;
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):684-90. PubMed ID: 20932658
[TBL] [Abstract][Full Text] [Related]
54. Squamous cell carcinoma of the anal margin.
Mendenhall WM; Zlotecki RA; Vauthey JN; Copeland EM
Oncology (Williston Park); 1996 Dec; 10(12):1843-8; discussion 1848, 1853-4. PubMed ID: 8985968
[TBL] [Abstract][Full Text] [Related]
55. [Squamous cell carcinoma of the anal canal showing complete response following chemoradiotherapy--a case report].
Tajima Y; Ishibashi K; Gonda T; Miyazaki T; Nakada H; Takahashi T; Ishida H
Gan To Kagaku Ryoho; 2007 Nov; 34(12):2050-2. PubMed ID: 18219895
[TBL] [Abstract][Full Text] [Related]
56. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
[TBL] [Abstract][Full Text] [Related]
57. [The role of radical surgery in the treatment of epidermoid carcinoma of the anal canal].
Luna-Pérez P; Fernández A; Labastida S; Acevedo C; Torres S; Padilla R; Herrera Ornelas L
Gac Med Mex; 1994; 130(5):380-5. PubMed ID: 7607369
[TBL] [Abstract][Full Text] [Related]
58. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
59. [New technologies in the diagnosis and treatment of patients with squamous cell carcinoma of the anal canal].
Malikhov AG; Barsukov IuA; Malikhova OA; Ungiadze GV; Timofeev IuM; Perfil'ev IB
Eksp Klin Gastroenterol; 2011; (10):73-7. PubMed ID: 22629704
[TBL] [Abstract][Full Text] [Related]
60. Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
Tahara M; Minami H; Kawashima M; Kawada K; Mukai H; Sakuraba M; Matsuura K; Ogino T; Hayashi R; Ohtsu A
Cancer Sci; 2011 Feb; 102(2):419-24. PubMed ID: 21134076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
